Fundraising Fox
Toronto · Seed–Series A · 12 people tracked
Also known as Genesys
Find your way into Genesys Capital
Sign up to see every warm intro you have to Genesys Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genesys Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Genesys Capital focuses on the high-growth sectors of biotechnology, pharmaceuticals, and medical technology, investing across the lifecycle from seed to commercial impact. Leveraging over 25 years of experience and long-standing partnerships with leading North American research institutes and universities, the firm gains early access to top-tier scientific discoveries and differentiated deal flow. Genesys often co-creates and builds companies alongside scientific founders and entrepreneurs, acting as a thought partner to shape the future of healthcare. Its strategy aims to deliver strong, repeatable returns to investors while advancing medicine that addresses pressing unmet medical needs.
Source: firm website, verified Aug 3, 2026.
Team · 12 people
from the firm's website & curated & public directories
What they invest in
from 11 of 22 portfolio companiesBiotech ×8Medical Devices ×6Deep Tech ×4Healthtech ×4AI & Machine Learning ×2Hardware ×2Digital Health ×1Enterprise Software ×1
HQs:Canada×4United States×3
Investments · 22 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 32021 · 12020 · 12019 · 28 dated
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.
BiotechDeep TechHealthtechMedical DevicesMississauga
Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)
BoardJean-Francois Pariseau(Director)Damian Lamb(Director)
Co-investorsCTI Life Sciences Fund L.P.FACIT (Fight Against Cancer Innovation Trust)
Adapsyn Bioscience is a biotech company focused on discovering and developing microbial natural product small molecules for therapeutic applications by leveraging genomic and chemical biology approaches.
AI & Machine LearningBiotechDeep TechHamilton, CA
Nathan Magarvey(Founder)
Co-investorsPfizer Venture Investments
Antegrade Medical is a Quebec City-based medical device startup developing single-use procedural tools enabling an antegrade approach for structural interventional cardiology procedures.
Cresta provides a unified platform combining human and AI agents to automate and augment customer service interactions for enterprise contact centers.
AI & Machine LearningEnterprise SoftwareSaaSSales TechSunnyvale, US
Sebastian Thrun(Founder)inTim Shi(Founder)inZayd Enam(Founder)inAndre Esteva(Founder)inShan Huang(Co-Founder)inPing Wu(Chief Executive Officer)in
Co-investorsAndreessen HorowitzTiger Global ManagementBallistic VenturesBrilliant Phoenix CapitalComcast VenturesGreylock Partners+17 more
Leading paint manufacturer in Ghana focused on West African exports.
Co-investorsAdenia PartnersAccenture VenturesAndreessen HorowitzGreylock PartnersLG Technology VenturesQualcomm Ventures+5 more
Cryostasis develops the Woolii SU (Subzero Unfrozen) platform, a preservation system that stores cell therapy products at subzero temperatures without freezing or cryoprotectants.
BiotechDeep TechHardwareHealthtechMedical Devices
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in
Co-investorsSV Health InvestorsToronto Innovation Acceleration Partners
Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment.
HealthtechMedical Devices
Co-investorsJobsOhio Ventures
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.
BiotechDeep TechMedical Devices
François-Thomas Michaud(Board Member & Chief Executive Officer)in
Co-investorsAsahi Kasei Corporate Venture CapitalLinearis VenturesFonds de solidarité FTQZynext Ventures
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesiGan PartnersNew Leaf Venture PartnersRBCx
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesPivotal Life SciencesSeroba Life SciencesVenture Ontario+6 more
Scalable, high throughput DNA sequencing platforms.
Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock
Portfolio company acquired by Novo Nordisk for $1.1B USD.
Co-investorsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovationsAmgen Ventures+2 more
This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms.
Biotech
Co-investorsCDP Venture CapitalIreland Strategic Investment FundAdams Street PartnersHealthCapOrbiMedPivotal Life Sciences+1 more
Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
Co-investorsAlumni VenturesHatteras Venture PartnersPappas CapitalSanofi VenturesAlexandriaJDRF T1D Fund+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Adapsyn Bioscience IncFunction NeuromodulationFusionGiiantGiiant Pharma IncQuestat IncVeralox Therapeutics Inc
Exits · 5
1 IPOs · 4 acquisitions · showing 4Profound MedicalNASDAQ: PROFFusionacq. by AlumniInversagoacq. by Novo NordiskVeraloxacq. by Cadrenal Therapeutics
Portfolio news
latest coverage across their companiesProfound Medical · stocktitan.net · Sep 3, 2026
Feldan Therapeutics · finsmes.com · Apr 17, 2025
Frequently asked questions
- How many investments has Genesys Capital made?
- Genesys Capital has 22 tracked investments, 5 of which have exited.
- What stage does Genesys Capital invest at?
- Genesys Capital invests at the Seed, Series A stages.
- What is Genesys Capital's typical check size?
- Genesys Capital typically writes checks of $730K – $3.6M.
- What sectors does Genesys Capital focus on?
- Genesys Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Genesys Capital located?
- Genesys Capital is headquartered in Toronto, CA.
- Who does Genesys Capital co-invest with?
- Genesys Capital most often shares deals with Amplify Capital, Arboretum Ventures, JobsOhio Ventures, among 15 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.